[HTML][HTML] Hepatitis C virus in the new era: perspectives in epidemiology, prevention, diagnostics and predictors of response to therapy

F Ansaldi, A Orsi, L Sticchi, B Bruzzone… - World journal of …, 2014 - ncbi.nlm.nih.gov
Despite the great successes achieved in the fields of virology and diagnostics, several
difficulties affect improvements in hepatitis C virus (HCV) infection control and eradication in …

[HTML][HTML] STAT proteins–key regulators of anti-viral responses, inflammation, and tumorigenesis in the liver

B Gao, H Wang, F Lafdil, D Feng - Journal of hepatology, 2012 - Elsevier
Since its discovery in the early 1990s, the Janus kinase (JAK)-signal transducer and
activator of transcription (STAT) signaling pathway has been found to play key roles in …

The genetic theory of infectious diseases: a brief history and selected illustrations

JL Casanova, L Abel - Annual review of genomics and human …, 2013 - annualreviews.org
Until the mid-nineteenth century, life expectancy at birth averaged 20 years worldwide,
owing mostly to childhood fevers. The germ theory of diseases then gradually overcame the …

Genome-wide association study identifies variants associated with progression of liver fibrosis from HCV infection

E Patin, Z Kutalik, J Guergnon, S Bibert, B Nalpas… - Gastroenterology, 2012 - Elsevier
BACKGROUND & AIMS: Polymorphisms in IL28B were shown to affect clearance of
hepatitis C virus (HCV) infection in genome-wide association (GWA) studies. Only a fraction …

[HTML][HTML] Single nucleotide polymorphisms and risk of hepatocellular carcinoma in cirrhosis

P Nahon, J Zucman-Rossi - Journal of hepatology, 2012 - Elsevier
Liver carcinogenesis is a complex and multi-factorial process, in which both environmental
and genetic features interfere and contribute to malignant transformation. Patients with …

Polymorphisms near IL28B and serologic response to peginterferon in HBeAg-positive patients with chronic hepatitis B

MJ Sonneveld, VWS Wong, AM Woltman, GLH Wong… - Gastroenterology, 2012 - Elsevier
BACKGROUND & AIMS: A limited number of patients with hepatitis B e antigen (HBeAg)-
positive chronic hepatitis B respond to treatment with peginterferon alfa (PEG-IFN). We …

Reversal, maintenance or progression: what happens to the liver after a virologic cure of hepatitis C?

YA Lee, SL Friedman - Antiviral research, 2014 - Elsevier
A sustained virological response (SVR) from HCV (synonymous with virological cure) leads
to decreased mortality, morbidity and improved quality of life, as well as a reduced incidence …

[PDF][PDF] Hepatitis C virus induces interferon‐λ and interferon‐stimulated genes in primary liver cultures

S Marukian, L Andrus, TP Sheahan, CT Jones… - …, 2011 - Wiley Online Library
Hepatitis C virus (HCV) replication in primary liver cells is less robust than that in hepatoma
cell lines, suggesting that innate antiviral mechanisms in primary cells may limit HCV …

The favorable IFNL3 genotype escapes mRNA decay mediated by AU-rich elements and hepatitis C virus–induced microRNAs

AP McFarland, SM Horner, A Jarret, RC Joslyn… - Nature …, 2014 - nature.com
IFNL3, which encodes interferon-λ3 (IFN-λ3), has received considerable attention in the
hepatitis C virus (HCV) field, as many independent genome-wide association studies have …

Deciphering the role of host genetics in susceptibility to severe COVID-19

ME Carter-Timofte, SE Jørgensen, MR Freytag… - Frontiers in …, 2020 - frontiersin.org
Coronavirus disease-19 (COVID-19) describes a set of symptoms that develop following
infection by the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). Whilst …